195 related articles for article (PubMed ID: 21297433)
1. Palliative reirradiation for progressive diffuse intrinsic pontine glioma.
Fontanilla HP; Pinnix CC; Ketonen LM; Woo SY; Vats TS; Rytting ME; Wolff JE; Mahajan A
Am J Clin Oncol; 2012 Feb; 35(1):51-7. PubMed ID: 21297433
[TBL] [Abstract][Full Text] [Related]
2. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
[TBL] [Abstract][Full Text] [Related]
3. Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group.
Müller K; Scheithauer H; Pietschmann S; Hoffmann M; Rössler J; Graf N; Baumert BG; Christiansen H; Kortmann RD; Kramm CM; von Bueren AO
Radiat Oncol; 2014 Aug; 9():177. PubMed ID: 25112658
[TBL] [Abstract][Full Text] [Related]
4. Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience.
Lassaletta A; Strother D; Laperriere N; Hukin J; Vanan MI; Goddard K; Lafay-Cousin L; Johnston DL; Zelcer S; Zapotocky M; Rajagopal R; Ramaswamy V; Hawkins C; Tabori U; Huang A; Bartels U; Bouffet E
Pediatr Blood Cancer; 2018 Jun; 65(6):e26988. PubMed ID: 29369515
[TBL] [Abstract][Full Text] [Related]
5. Reirradiation of recurrent breast cancer with and without concurrent chemotherapy.
Würschmidt F; Dahle J; Petersen C; Wenzel C; Kretschmer M; Bastian C
Radiat Oncol; 2008 Sep; 3():28. PubMed ID: 18801165
[TBL] [Abstract][Full Text] [Related]
6. Proton therapy for reirradiation of progressive or recurrent chordoma.
McDonald MW; Linton OR; Shah MV
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1107-14. PubMed ID: 24267972
[TBL] [Abstract][Full Text] [Related]
7. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
Kline C; Liu SJ; Duriseti S; Banerjee A; Nicolaides T; Raber S; Gupta N; Haas-Kogan D; Braunstein S; Mueller S
J Neurooncol; 2018 Dec; 140(3):629-638. PubMed ID: 30206764
[TBL] [Abstract][Full Text] [Related]
8. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.
McAvoy S; Ciura K; Wei C; Rineer J; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):819-27. PubMed ID: 25220718
[TBL] [Abstract][Full Text] [Related]
9. A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma.
Amsbaugh MJ; Mahajan A; Thall PF; McAleer MF; Paulino AC; Grosshans D; Khatua S; Ketonen L; Fontanilla H; McGovern SL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):144-148. PubMed ID: 30610915
[TBL] [Abstract][Full Text] [Related]
10. Chemo-reirradiation in persistent/recurrent head and neck cancers.
Nagar YS; Singh S; Datta NR
Jpn J Clin Oncol; 2004 Feb; 34(2):61-8. PubMed ID: 15067097
[TBL] [Abstract][Full Text] [Related]
11. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
12. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
13. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
[TBL] [Abstract][Full Text] [Related]
14. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
[TBL] [Abstract][Full Text] [Related]
15. Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer.
Rusthoven KE; Feigenberg SJ; Raben D; Kane M; Song JI; Nicolaou N; Mehra R; Burtness B; Ridge J; Swing R; Lango M; Cohen R; Jimeno A; Chen C
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1020-5. PubMed ID: 20231078
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.
Bouffet E; Raquin M; Doz F; Gentet JC; Rodary C; Demeocq F; Chastagner P; Lutz P; Hartmann O; Kalifa C
Cancer; 2000 Feb; 88(3):685-92. PubMed ID: 10649264
[TBL] [Abstract][Full Text] [Related]
17. Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma.
Sethi R; Allen J; Donahue B; Karajannis M; Gardner S; Wisoff J; Kunnakkat S; Mathew J; Zagzag D; Newman K; Narayana A
J Neurooncol; 2011 Mar; 102(1):121-7. PubMed ID: 20623246
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort.
Scholtyssek F; Zwiener I; Schlamann A; Seidel C; Meixensberger J; Bauer M; Hoffmann KT; Combs SE; von Bueren AO; Kortmann RD; Müller K
Radiat Oncol; 2013 Jul; 8():161. PubMed ID: 23822643
[TBL] [Abstract][Full Text] [Related]
19. Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma.
Broniscer A; Jia S; Mandrell B; Hamideh D; Huang J; Onar-Thomas A; Gajjar A; Raimondi SC; Tatevossian RG; Stewart CF
Pediatr Blood Cancer; 2018 Jul; 65(7):e27035. PubMed ID: 29512900
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
